Rare diseases
Investigational molecules
Locations
Evaluating Dapagliflozin's Effect on Immune Activity in Patients with Membranous Nephropathy
FranceStudy on the Safety and Effectiveness of Dapagliflozin for Kidney Function in Non-Diabetic Kidney Transplant Patients
DenmarkStudy on Using Dapagliflozin, Semaglutide, and Finerenone to Prevent Heart and Kidney Complications in Patients with Type 2 Diabetes
DenmarkStudy on Dapagliflozin for Heart and Kidney Health in Adults After ICU Discharge with Heart or Kidney Issues
FranceStudy on Dapagliflozin for Patients with Chronic Right Heart Failure
GermanyStudy on the Effects of Dapagliflozin on Kidney Health in Patients with Chronic Kidney Disease After Kidney Transplantation
GermanyStudy on Dapagliflozin for Slowing Kidney Disease in Adolescents and Young Adults with Alport Syndrome
GermanyStudy on the Effects of Semaglutide, Dapagliflozin, and Metformin in Patients with Coronary Artery Disease and Prediabetes
PolandStudy of Dapagliflozin to Preserve Function in Transplanted Kidneys
NorwayStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
AustriaStudy on the Effects of Ramipril, Bisoprolol, and Dapagliflozin in Patients with ST-Elevation Myocardial Infarction (Heart Attack)
DenmarkStudy on Dapagliflozin for Patients with Decompensated Liver Cirrhosis
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
